Interoperability Bidco, Inc.

Interoperability Bidco, Inc., doing business as Rhapsody, a foreign-owned for-profit software company headquartered in Boston, Massachusetts, supplies public health surveillance and healthcare data integration software (the Rhapsody platform) to federal agencies primarily as a prime contractor (79% of recent awards) under full-and-open competition with no recurring set-aside posture.

Rhapsody's federal footprint is heavily concentrated in health IT and disease surveillance. The Centers for Disease Control and Prevention accounts for 89% of the award count and 51% of combined potential value across all recent work — eighteen awards totaling $558 thousand, spanning software licenses, cloud hosting, maintenance, and implementation services for programs including the National Healthcare Safety Network (NHSN), Electronic Laboratory Information Management System (ELIMS), and Mortality and Morbidity Surveillance Programs (MVPS). The Department of Veterans Affairs anchors the second-largest dollar commitment with a single $404 thousand definitive contract awarded November 2024 for CorePoint license and support in the VISN 23 VA Healthcare System, running through October 2030. The Department of Agriculture rounds out top-three concentration with two awards totaling $117 thousand split between the Animal and Plant Health Inspection Service and the Office of the Chief Information Officer. Recent work includes a $66.8 thousand CDC purchase order for Rhapsody software licenses and maintenance through August 2027, a $67.3 thousand CDC order for NHSN operations, and a $32.9 thousand CDC order for ELIMS-related services, all awarded in 2025–2026.

Rhapsody's subcontractor footprint routes through Leidos, which has engaged the vendor on four sub-awards since August 2024 for MHS Genesis operational and license-maintenance services and Indian Health Service electronic dental records (EDR) implementation support. The vendor also appears as a sub-recipient under state health departments: the Indiana Department of Health engaged Rhapsody on two public health grant sub-awards (Public Health Emergency Preparedness and Epidemiology and Laboratory Capacity for the Prevention and Control of Emerging Infectious Disease) in 2025–2026.

Activity has remained roughly flat at three to six awards per year from 2022 through 2026, with the most recent award dated September 23, 2026. Three awards face ultimate completion within the next twenty-four months, carrying combined potential value of $161 thousand and representing near-term recompete exposure. The vendor does not hold a seat on major government-wide acquisition contracts; task-order activity appears under subordinate vehicles including the Chief Information Officer Solutions and Partners 3 and an indefinite delivery contract (N0003915D0044). All federal awards carry firm fixed-price terms and place work in Boston.